IL155920A0 - Aerogel powder comprising therapeutic agents - Google Patents
Aerogel powder comprising therapeutic agentsInfo
- Publication number
- IL155920A0 IL155920A0 IL15592001A IL15592001A IL155920A0 IL 155920 A0 IL155920 A0 IL 155920A0 IL 15592001 A IL15592001 A IL 15592001A IL 15592001 A IL15592001 A IL 15592001A IL 155920 A0 IL155920 A0 IL 155920A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agents
- aerogel powder
- aerogel
- powder
- therapeutic
- Prior art date
Links
- 239000004964 aerogel Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000000843 powder Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25743600P | 2000-12-22 | 2000-12-22 | |
| PCT/US2001/049541 WO2002051389A2 (en) | 2000-12-22 | 2001-12-21 | Aerogel powder comprising therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155920A0 true IL155920A0 (en) | 2003-12-23 |
Family
ID=22976300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15592001A IL155920A0 (en) | 2000-12-22 | 2001-12-21 | Aerogel powder comprising therapeutic agents |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6994842B2 (xx) |
| EP (1) | EP1343479A2 (xx) |
| JP (1) | JP2004516304A (xx) |
| KR (1) | KR20030077544A (xx) |
| CN (1) | CN1481236A (xx) |
| BR (1) | BR0115524A (xx) |
| CA (1) | CA2429773A1 (xx) |
| IL (1) | IL155920A0 (xx) |
| MX (1) | MXPA03004340A (xx) |
| RU (1) | RU2003122515A (xx) |
| WO (1) | WO2002051389A2 (xx) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10214226B4 (de) * | 2001-10-11 | 2009-07-16 | Arlt, Wolfgang | Wirkstoffträger, Verfahren zu dessen Herstellung und Verwendung |
| US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
| US6931888B2 (en) * | 2003-02-07 | 2005-08-23 | Ferro Corporation | Lyophilization method and apparatus for producing particles |
| US20040180915A1 (en) * | 2003-03-14 | 2004-09-16 | Xanodyne Pharmacal, Inc. | Methadone-containing compositions for parenteral administration and method of use thereof |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| KR101053558B1 (ko) * | 2004-03-30 | 2011-08-03 | 유로-셀띠끄 소시에떼 아노님 | 흡착제 및 억제제를 포함하는 내변조성 제형 |
| WO2006016981A2 (en) * | 2004-07-12 | 2006-02-16 | Ferro Corporation | Production of porous materials by supercritical fluid processing |
| US20060127442A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Use of supercritical fluids to incorporate biologically active agents into nanoporous medical articles |
| WO2009062975A1 (en) * | 2007-11-12 | 2009-05-22 | Cismi | Aerogel compositions |
| EP2130877A1 (en) | 2008-06-06 | 2009-12-09 | Fibac ApS | Gel compositions |
| US20100183687A1 (en) * | 2009-01-22 | 2010-07-22 | Cox D Phillip | Process for preparing particles of opioids and compositions produced thereby |
| US9125872B2 (en) * | 2009-10-13 | 2015-09-08 | Yosry A. Attia | Polyethylene glycol aerogels for targeted delivery of pharmaceutical drubs |
| JP5883687B2 (ja) * | 2011-03-09 | 2016-03-15 | 第一三共ヘルスケア株式会社 | Ｐｄｅ５阻害剤含有医薬組成物 |
| CN102961342B (zh) * | 2012-12-13 | 2014-11-26 | 清华大学深圳研究生院 | 纳米级卡培他滨及其制备方法 |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757529B2 (en) * | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| CN105473133A (zh) | 2013-04-30 | 2016-04-06 | 欧缇托匹克公司 | 干粉制剂及使用方法 |
| CA2977083A1 (en) | 2014-02-20 | 2015-08-27 | Kambiz Yadidi | Dry powder formulations for inhalation |
| US20160058045A1 (en) * | 2014-08-26 | 2016-03-03 | Pepsico, Inc. | Method of Loading Flavor into an Aerogel and Flavor Impregnated Aerogel Based on Food Grade Materials |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| KR20230040375A (ko) | 2017-09-22 | 2023-03-22 | 오티토픽 인코퍼레이티드 | 스테아르산마그네슘을 갖는 건조 분말 조성물 |
| EP3822395A1 (en) * | 2019-11-13 | 2021-05-19 | Fundación Imdea Materiales | Nanowires network |
| WO2023170135A1 (en) | 2022-03-08 | 2023-09-14 | Aerogel-It Gmbh | Process for producing porous materials |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994008599A1 (en) * | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
| GB9313501D0 (en) | 1993-06-30 | 1993-08-11 | Nycomed Imaging As | Improvements in or relating to polymer materials |
| EP0728037B1 (en) * | 1993-11-08 | 1999-01-13 | The Gillette Company | Method of forming particles using a supercritical fluid, aerogel particles formed thereby, and antiperspirants containing aerogel particles |
| AU696387B2 (en) * | 1994-05-18 | 1998-09-10 | Inhale Therapeutic Systems, Inc. | Methods and compositions for the dry powder formulation of interferons |
| AU751582B2 (en) * | 1995-02-22 | 2002-08-22 | Cabot Corporation | Use of inorganic aerogels in pharmacy |
| DE19506141A1 (de) * | 1995-02-22 | 1996-08-29 | Hoechst Ag | Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz |
| US5958589A (en) * | 1995-07-07 | 1999-09-28 | The United States Of America As Represented By The Secretary Of Agriculture | Starch-based microcellular foams |
| US6120751A (en) * | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
| US6277489B1 (en) * | 1998-12-04 | 2001-08-21 | The Regents Of The University Of California | Support for high performance affinity chromatography and other uses |
-
2001
- 2001-12-21 CN CNA018209742A patent/CN1481236A/zh active Pending
- 2001-12-21 EP EP01992223A patent/EP1343479A2/en not_active Withdrawn
- 2001-12-21 KR KR10-2003-7006998A patent/KR20030077544A/ko not_active Application Discontinuation
- 2001-12-21 US US10/034,444 patent/US6994842B2/en not_active Expired - Fee Related
- 2001-12-21 CA CA002429773A patent/CA2429773A1/en not_active Abandoned
- 2001-12-21 WO PCT/US2001/049541 patent/WO2002051389A2/en active Application Filing
- 2001-12-21 IL IL15592001A patent/IL155920A0/xx unknown
- 2001-12-21 JP JP2002552535A patent/JP2004516304A/ja active Pending
- 2001-12-21 BR BR0115524-5A patent/BR0115524A/pt not_active Application Discontinuation
- 2001-12-21 RU RU2003122515/15A patent/RU2003122515A/ru not_active Application Discontinuation
- 2001-12-21 MX MXPA03004340A patent/MXPA03004340A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US20020094318A1 (en) | 2002-07-18 |
| WO2002051389A2 (en) | 2002-07-04 |
| KR20030077544A (ko) | 2003-10-01 |
| EP1343479A2 (en) | 2003-09-17 |
| CN1481236A (zh) | 2004-03-10 |
| WO2002051389A3 (en) | 2003-01-16 |
| US6994842B2 (en) | 2006-02-07 |
| RU2003122515A (ru) | 2005-01-27 |
| MXPA03004340A (es) | 2005-01-25 |
| JP2004516304A (ja) | 2004-06-03 |
| CA2429773A1 (en) | 2002-07-04 |
| BR0115524A (pt) | 2003-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0012671D0 (en) | Therapeutic agents | |
| GB0003397D0 (en) | Therapeutic agents | |
| GB0004003D0 (en) | Therapeutic agents | |
| GB0018473D0 (en) | Therapeutic agents | |
| EP1296698A4 (en) | THERAPEUTIC COMPOUNDS | |
| IL155920A0 (en) | Aerogel powder comprising therapeutic agents | |
| GB0017256D0 (en) | Therapeutic agents | |
| GB0028429D0 (en) | Therapy | |
| GB0027561D0 (en) | Therapeutic agents | |
| GB0005789D0 (en) | Therapeutic agents | |
| GB0007907D0 (en) | Therapeutic agents | |
| GB0012214D0 (en) | Therapeutic agents | |
| GB0008696D0 (en) | Therapeutic agents | |
| GB0023610D0 (en) | Therapeutic agents | |
| GB0000564D0 (en) | Therapeutic agents | |
| GB0020721D0 (en) | Therapeutic agents | |
| GB0017518D0 (en) | Therapeutic agents | |
| GB0007376D0 (en) | Therapeutic agents | |
| GB0030067D0 (en) | Therapeutic agent | |
| GB0017543D0 (en) | Therapeutic agents | |
| GB0119370D0 (en) | Therapeutic agent | |
| GB0022988D0 (en) | Therapeutic agents | |
| GB0017049D0 (en) | Therapeutic agent | |
| GB0018619D0 (en) | Therapeutic agents | |
| GB0006717D0 (en) | Therapeutic agents |